Navigation Links
Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
Date:12/21/2009

x, Inc. (Soligenix), formerly known as DOR BioPharma, Inc., is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a common and potentially life-threatening complication of hematopoietic cell transplantation. orBec® is currently the subject of a confirmatory Phase 3 clinical trial for the treatment of acute GI GVHD and an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in the prevention of acute GVHD. Both of these trials are actively enrolling patients. Soligenix has also recently initiated an NIH-supported Phase 1/2 clinical trial of SGX201 in the prevention of acute radiation enteritis. Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.

Through its Biodefense Division, Soligenix is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. Soligenix's lead biodefense product in development is a recombinant subunit vaccine called RiVax(TM) which is designed to protect against the lethal effects of exposure to ricin toxin. RiVax(TM) has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers. RiVax(TM) will also be the subject of a recent $9.4 million NIH grant received by the Company supporting development of new heat stable vaccines.

For further information regarding Soligenix, Inc., please visit the Company's website at

SOURCE Soligenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015   Wilson Therapeutics AB , a ... Schikan to its board of directors. The appointment was ... on June 30. "We are delighted to ... Jonas Hansson , CEO of Wilson Therapeutics. "Hans brings ... look forward to his contributions to the Company." ...
(Date:7/1/2015)... 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... corporate presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief ... a business and financial update on Wednesday, July 8, 2015 ... A live audio webcast of the presentation may be ...
(Date:7/1/2015)... 1, 2015 Eli Lilly and Company (NYSE: ... quarter of 2015 on Thursday, July 23, 2015. Lilly will ... investment community and media to further detail the company,s financial ... a.m. EDT. Investors, media and the general public can access ... that will be posted on Lilly,s website at www.lilly.com ...
Breaking Medicine Technology:Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2
... MOUNTAIN VIEW, Calif., Jan. 24, 2011 Based on ... (PERS) market, Frost & Sullivan recognizes BeClose with the ... Innovation of the Year for its innovative BeClose System ... (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) While PERS ...
... Jan. 24, 2011 PharmAthene, Inc. (NYSE Amex: ... Court of Chancery, which commenced January 3, 2011, in its ... Friday, January 21, 2011. The Company anticipates that post trial ... of the court will be complete by the end of ...
Cached Medicine Technology:Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 2Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 3Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 4PharmAthene Provides Update on Litigation With SIGA Technologies 2
(Date:7/2/2015)... PEACHTREE CITY, GA (PRWEB) , ... July 02, 2015 , ... ... introduce their newest innovation in compression socks designed for men. , For style ... compression socks into their daily routine. This is great news for men everywhere because ...
(Date:7/2/2015)... ... July 02, 2015 , ... When The ... for the late June Web-based session, the speakers discussed the importance of accountable ... high-risk patients through coordinated care. , During the session, participants learned the ins ...
(Date:7/2/2015)... ... 02, 2015 , ... Facial plastic surgery is about more ... an art and science that goes into successful facial reconstruction and contouring. Dr. ... and lives of more than 2,500 satisfied facelift and neck lift patients alone. ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... recently received nearly $4 million through five federal grants to study a group ... against the deadly diseases. , The research will be conducted in the ...
(Date:7/2/2015)... Lenexa, Kan. (PRWEB) , ... July 02, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... One of the top executive search firms in the healthcare industry, B. E. ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3
... Didrick of Naples, Florida, has come up with a fascinating ... in 150 persons do lose a digit , it is ... because it has no batteries, electronics, servos or actuators. Instead, ... the surviving part of the wearer's finger, curls a set ...
... Indian-born film director Mira Nair has launched an AIDS awareness ... and its danger to society . ,The project, ... will use the powerful medium of Indian cinema to inform ... showing of short films on the impact of the disease ...
... is experimenting with ways to add fibre to the foods ... snacks . ,Sajid Alavi is an assistant professor ... ,His expertise is in extrusion processing, which ... food. ,Alavi is researching how this process ...
... disorders are also costing the nation a lot of money ... said . Griffith University has been working with Queensland Health ... cost of sleep disorders. ,Often general practitioners do ... deal with the diagnosis of sleep disorders, so they err ...
... and superstar footballer David Beckham are among celebrities whose sketches ... . ,Artist Rich Clarke, who created the artworks, ... that follows a serial killer, working for the police and ... assigned the task of making these artworks by FX Channel ...
... using garment integrated electronic technology to develop smart garments that, ... be downloaded in a heartbeat to a computer in your ... ,Imagine wearing a smart T-shirt or a suit embedded with ... wirelessly. When dirty, you take it off and throw it ...
Cached Medicine News:Health News:A Mechanical Prosthetic Close to the Real Thing 2Health News:Now, Fibre-enriched Tasty Snacks in the Making 2Health News:An Offbeat Suit With Electronic Monitor 2
The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...
Multiparameter laser and arc lamp flow cytometer for all applications in immunology, microbiology, cell biology, pathology, hematology, lymphocyte dubset and cell analysis....
... Compact mobile flow cytometer for ... absolute volumetric counting. The CyFlow SL ... in combination with up to 3 ... real-time display is performed with a ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
Medicine Products: